Switch to:
More From Other Websites
Will Valeant Pharmaceuticals Recover after Appointing a New CEO? Apr 29 2016
The 3 Largest Global Ex-U.S. ETFs (VEU, VXUS) Apr 28 2016
Valeant Pharmaceuticals’ 10-K for 2015: The Wait Continues Apr 28 2016
4 Ways an Economy Can Deleverage: Ray Dalio Explains Apr 26 2016
What Economic Factors Will the UK Consider in the Brexit Decision? Apr 19 2016
How Much Potential Does Saxenda Hold for Novo? Apr 17 2016
Why Have HollyFrontier’s Cash Reserves Fallen Steeply? Apr 17 2016
Developing Nations Increase Borrowing Apr 17 2016
US Factory Orders Fell in February: What Does It Mean? Apr 11 2016
Teva’s Asthma Segment: What Could Its Boost Revenues in 2016? Apr 06 2016
Analyzing Valero’s Cash Flow: Increasing Shareholders’ Returns Apr 06 2016
Foreign Equities Turning Lower Again Apr 06 2016
How Has HFC’s Stock Performed since February 2016? Mar 31 2016
How Could Generic Competition Affect Copaxone’s Revenues in 2016? Mar 30 2016
Service Sector Helped France’s PMI Index Rise in March Mar 29 2016
Six Advanced Studies for Roche’s Atezolizumab Mar 28 2016
Inside Roche’s Next Oncology Portfolio Drivers Mar 28 2016
Does Consolidation Favor A Big Move Up Or Down? Mar 25 2016
7 Vanguard ETFs Reducing Fees in 2016 (VEU, VSS) Mar 23 2016
(VEU) Vanguard All World ex-US. ETF: Top 5 Holdings Mar 19 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK